Excellent Outcome Following Haplo-Identical and Unrelated Donor HSCT for Young Patients with Sever Aplastic Anemia Using Reduced Dose TBI and Post-Transplant Cyclophosphamide for Gvhd Prophylaxis

Severe aplastic anemia (SAA) is a potentially fatal hematologic disorder that can be cured with hematopoietic stem cell transplantation (HSCT). Although the outcomes with HLA-identical siblings are favorable, the majority of patients lack suitable HLA-identical donors.

Source: Biology of Blood and Marrow Transplantation - February 1, 2024 Category: Hematology Authors: Ayad Ahmed Hussein, Clinton Carroll, Noor Awni Ghanem, Bayan Majed Alaraj, Jennifer Domm, Tariq Ahmed Abdelghani, Meghann McManus, Dina Mohammad Abu Assab, Hadeel Hassan Alzoubi, Misty Evans, Haydar Frangoul Tags: 213 Source Type: research